The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.
a cool $63bn (which was also notable for putting the world’s best-selling drug Humira under the same roof as Botox).
specialists aren’t rushing to switch wholesale from other migraine preventative therapies like Allergan’s Botox.
year. Botox is facing tougher competition in the market from new migraine drugs as well as rivals in its medical aesthetics indications. ... The latter is still low level, however, and biosimilars to Botox are thought to be some years off the market.
as Dysport (abobotulinumtoxinA), a rival to Allergan’s big-selling Botox brand.
The US specialised therapeutics business – which include Botox – posted just 0.7% growth in the quarter to $1.82bn as medical aesthetics products Juvederm and Restasis posted sales declines. ... AbbVie has already announced plans to spin off the
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...